As of March 18, analysts expect significant growth in CannTrust’s sales in the fourth quarter. The company is estimated to report sales of 20.7 million Canadian dollars, which will likely grow almost 197% year-over-year from 6.9 million Canadian dollars in the fourth quarter of 2017. The company’s revenues are estimated to grow 65% sequentially.

CannTrust’s peers (MJ) including Canopy Growth (WEED), Aphria (APHA), and HEXO (HEXO) reported significant growth in their recent quarterly revenues due to the legalization of recreational cannabis in Canada.

In the fourth quarter, we’ll have to see CannTrust’s sales and prices. These two drivers will likely be a key focus to gauge CannTrust’s future position among its peers.

Next, we’ll discuss CannTrust’s profitability expectations.